DanielGeorgeBakerMD

PubMed

• 11 citations
  The shared susceptibility epitope of HLA-DR4 binds citrullinated self-antigens and the TCR
  Jia Jia Lim, Claerwen M. Jones, Tiing Jen Loh, Yi Tian Ting, Pirooz Zareie, Khai Lee Loh, Nathan J. Felix, Anish Suri, Murray McKinnon, Frederik Stevenaert, Ravi Sharm...> ;Science Immunology. 2021 Apr 16
• 46 citations
  PD-L1– and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease
  Ryan Galea, Hendrik J. Nel, Meghna Talekar, Xiao Liu, Joshua D. Ooi, Megan Huynh, Sara Hadjigol, Kate J. Robson, Yi Tian Ting, Suzanne Cole, Karyn Cochlin, Shannon Hit...> ;JCI Insight. 2019 Sep 19
• 17 citations
  Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis.
  Carson Maynard, Ted R. Mikuls, Grant W. Cannon, Bryant R. England, Philip G. Conaghan, Mikkel Østergaard, Daniel Baker, Gail S. Kerr, Michael D. George, Jennifer L. Ba...> ;Arthritis Care & Research. 2020 Mar 1
• 4 citations
  Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-m...
  Tsutomu Takeuchi, Masayoshi Harigai, Yoshiya Tanaka, Hisashi Yamanaka, Naoki Ishiguro, Kazuhiko Yamamoto, Nobuyuki Miyasaka, Takao Koike, Yoshifumi Ukyo, Yutaka Ishii,...> ;Modern Rheumatology. 2018 Sep 1
• 61 citations
  The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis.
  Yi Tian Ting, Jan Petersen, Sri H. Ramarathinam, S.W. Scally, Khai Lee Loh, Ranjeny Thomas, Anish Suri, Daniel Baker, Anthony W. Purcell, Hugh H. Reid, Jamie Rossjohn> ;The Journal of Biological Chemistry. 2018 Mar 2
• 3 citations
  Early response to therapy predicts 6-month and 1-year disease activity outcomes in psoriatic arthritis patients.
  Monika Schoels, U Landesmann, Farideh Alasti, Daniel Baker, Josef S Smolen, Daniel Aletaha> ;Rheumatology. 2018 Jun 1
• 31 citations
  The effects of structural damage on functional disability in psoriatic arthritis
  Andreas Kerschbaumer, Daniel Baker, Josef S Smolen, Daniel Aletaha> ;Annals of the Rheumatic Diseases. 2017 Dec 1
• 28 citations
  The molecular basis for peptide repertoire selection in the human leucocyte antigen (HLA) C*06:02 molecule.
  Jesse I. Mobbs, Patricia T. Illing, Nadine L. Dudek, Andrew G. Brooks, Daniel Baker, Anthony W. Purcell, Jamie Rossjohn, Julian P. Vivian> ;The Journal of Biological Chemistry. 2017 Oct 20
• 29 citations
  Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis.
  Michael D. George, Mikkel Østergaard, Philip G. Conaghan, Paul Emery, Daniel Baker, Joshua F. Baker> ;Annals of the Rheumatic Diseases. 2017 Jun 12
• 35 citations
  Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis
  Joshua F. Baker, Philip G. Conaghan, Paul Emery, Daniel Baker, Mikkel Østergaard> ;Annals of the Rheumatic Diseases. 2017 Mar 1
• 10 citations
  Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression.
  Joshua F. Baker, Mikkel Østergaard, Paul Emery, Daniel Baker, Philip G. Conaghan> ;Clinical and Experimental Rheumatology. 2017 Jan 27
• 12 citations
  Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies.
  Robin L. Thurmond, Andrew Greenspan, Waldemar Radziszewski, Xie L. Xu, Ye Miao, Bin Chen, Ting Ting Ge, B. Zhou, Daniel Baker, Dace Pavlova, Christopher T. Ritchlin, Y...> ;The Journal of Rheumatology. 2016 Jul 15
• 12 citations
  Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients ...
  Yoshiya Tanaka, Masayoshi Harigai, Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Kazuhiko Yamamoto, Nobuyuki Miyasaka, Takao Koike, Daniel Baker, Yutaka Ishii, T...> ;Modern Rheumatology. 2016 Jul 3
• 26 citations
  Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis
  Joshua F. Baker, Philip G. Conaghan, Paul Emery, Daniel Baker, Mikkel Østergaard> ;Annals of the Rheumatic Diseases. 2016 Jun 1
• 6 citations
  Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics Trials
  Maarten Boers, Daniel Aletaha, Christopher M Mela, Daniel Baker, Josef S Smolen> ;The Journal of Rheumatology. 2016 Jun 1
• 5 citations
  Prevention of joint destruction in patients with high disease activity or high C-reactive protein levels: Post hoc analysis of the GO-FORTH study
  Yoshiya Tanaka, Masayoshi Harigai, Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Kazuhiko Yamamoto, Yutaka Ishii, Hiroshi Nakajima, Daniel Baker, Nobuyuki Miyasa...> ;Modern Rheumatology. 2016 May 3
• 5 citations
  Evaluation of golimumab for the treatment of patients with active rheumatoid arthritis
  Yoshiya Tanaka, Asako Senoo, Hideji Fujii, Daniel Baker> ;Expert Opinion on Drug Metabolism & Toxicology. 2016 Feb 15
• 97 citations
  A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis d...
  Josef S Smolen, Sandeep K. Agarwal, Elena Ilivanova, Xie Lillian Xu, Ye Miao, Yanli Zhuang, Ivo Nnane, Waldemar Radziszewski, Andrew Greenspan, A. Beutler, Daniel Baker> ;Annals of the Rheumatic Diseases. 2015 Jun 1
• 36 citations
  Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: ...
  Michael E. Weinblatt, Rene Westhovens, Alan M. Mendelsohn, L. Kim, Kim Hung Lo, Shihong Sheng, L. Noonan, J. Lu, Zhenhua Xu, Jocelyn H. Leu, Daniel Baker, Clifton O. B...> ;Annals of the Rheumatic Diseases. 2014 Dec 1
• 70 citations
  Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1–2 years
  Joshua F. Baker, Mikkel Østergaard, Michael D. George, Justine Shults, Paul Emery, Daniel Baker, Philip G. Conaghan> ;Annals of the Rheumatic Diseases. 2014 Nov 1
• Reply: To PMID 24757132.
  Joshua F. Baker, Josef S. Smolen, Daniel Aletaha, Justine Shults, Philip G. Conaghan, Paul Emery, Daniel Baker, Mikkel Østergaard> ;Arthritis & Rheumatology. 2014 Nov 1
• 9 citations
  Efficacy of golimumab plus methotrexate in methotrexate-naïve patients with severe active rheumatoid arthritis
  Paul Emery, Roy Fleischmann, Elizabeth C. Hsia, Stephen Xu, Yiying Zhou, Daniel Baker> ;Clinical Rheumatology. 2014 Jul 9
• 12 citations
  The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial.
  Clifton O. Bingham, Michael E. Weinblatt, Chenglong Han, T. Gathany, L. Kim, Kim Hung Lo, Daniel Baker, Alan M. Mendelsohn, Rene Westhovens> ;The Journal of Rheumatology. 2014 Jun 1
• 49 citations
  Development and validation of modified disease activity scores in rheumatoid arthritis: superior correlation with magnetic resonance imaging-detected synovitis and rad...
  Joshua F. Baker, Philip G Conaghan, Josef S Smolen, Daniel Aletaha, Justine Shults, Paul Emery, Daniel Baker, Mikkel Østergaard> ;Arthritis & Rheumatology. 2014 Apr 1
• Development and validation of modified disease activity scores in rheumatoid arthritis: Superior correlation with MRI synovitis and X-ray progression.
  Baker, J. F.,Conaghan, P. G.,Smolen, J. S.,Aletaha, D.,Shults, J.,Emery, P.,Baker, D. G.,Ostergaard, M.> ;Arthritis Rheum.. 2013 Dec 18
• Join now to see all